Request for Institutional Price Quote or Complimentary Trial for Online Resources

Science is a leading outlet for scientific news, commentary, and cutting-edge research. Through its print and online incarnations, Science reaches an estimated worldwide readership of more than one million. Science’s authorship is global too, and its articles consistently rank among the world's most cited. Science seeks to publish those papers that are most influential in their fields or across fields and that will significantly advance scientific understanding. Selected papers should present novel and broadly important data, syntheses, or concepts. They should merit recognition by the wider scientific community and general public provided by publication in Science, beyond that provided by specialty journals.

Science Classic is the ideal complement to the online version of Science which provides access from 1997 to the current issue. The digital archives are fully integrated with the current content of Science which makes it easier to search the entire collection. Readers will have at their fingertip’s key articles in the history of science from the late 19th through the early 21st centuries, including research about the human genome, breast and colon cancer genes, and the Bose-Einstein condensate in physics.

Science Signaling is appropriate for organizations that support the research and study of biochemistry, cellular and molecular biology, immunology, neuroscience, pharmacology, physiology and medicine, and plant biology. Topics covered include molecular mechanisms of signaling and regulation within cells and the mechanisms by which cells and organisms communicate and affect each other’s behavior, signaling relevant to human physiology and disease and to plant physiology that is important for agriculture, and signaling between animals or plants and their commensal microbes and pathogens.

Science Translational Medicine is appropriate for researchers and management in academia, government, and the biotechnology and pharmaceutical industries, physician scientists, regulators, policy makers, investors, business developers, and funding agencies. Topics covered include bioengineering cancer, cardiovascular disease, diabetes and other metabolic diseases, drug development and delivery, genomic medicine, infectious diseases, immunology and vaccines, bioengineering, pharmacokinetics, neurology, psychiatry, medical informatics, and regenerative medicine.

Science Immunology is appropriate for organizations that support the research and study of cell biology, immunology, transplantation, and infectious diseases. Topics covered include host defense, inflammation, cancer immunology, autoimmunity, allergy, immunodeficiency, immunogenomics, systems immunology, structural immunology, antigen presentation, immunometabolism, and mucosal immunology.

Science Robotics is appropriate for organizations that support the research and study of robotics, mechanical engineering, biomechanics, civil engineering, electrical engineering, artificial intelligence, human computer interaction (HCI), and ethics. Topics covered include micro/nano robots, land and undersea robots, medical and surgical robots, space robots, marine and agricultural robots, artificial intelligence, biomaterials, biorobotics, and theoretical advances in robotics.